Apoptosis signaling through CD95 (Fas/APO-1) involves aggregation and clustering of the receptor followed by its actin-dependent internalization. Internalization is required for efficient formation of the death-inducing signaling complex (DISC) with maximal recruitment of FADD, caspase-8/10 and c-FLIP occurring when the receptor has reached an endosomal compartment. The first detectable event during CD95 signaling is the formation of SDS-stable aggregates likely reflecting intense oligomerization of the receptor. We now demonstrate that these SDS-stable forms of CD95 correspond to very high molecular weight DISC complexes (hiDISC) and are the sites of caspase-8 activation. hiDISCs are found both inside and outside of detergent-resistant membranes. The formation of SDS-stable CD95 aggregates involves palmitoylation of the membrane proximal cysteine 199 in CD95. Cysteine 199 mutants no longer form SDS-stable aggregates, and inhibition of palmitoylation reduces internalization of CD95 and activation of caspase-8. Our data demonstrate that SDS-stable forms of CD95 are the sites of apoptosis initiation and represent an important early step in apoptosis signaling through CD95 before activation of caspases.
Introduction
Apoptosis can be induced by a family of cell surface receptors known as death receptors (DRs) which include CD95 (Fas/APO-1), TNF-R1 and the two TRAIL receptors DR4 and DR5 . Like all DRs, CD95 carries a conserved stretch of 80 amino acids in its cytoplasmic tail known as the death domain (DD) that is essential for apoptosis initiation. Upon binding of CD95 ligand (CD95L), CD95 assembles the death-inducing signaling complex (DISC) at its DD comprised of CD95, the adaptor molecule FADD, procaspase-8, procaspase-10 and the caspase-8/10 regulator c-FLIP (Kischkel et al, 1995; Muzio et al, 1996; Chang et al, 2002; Peter and Krammer, 2003; Peter et al, 2003) . It is thought that the oligomerization of caspase-8 results in its cleavage and release from the DISC as an active heterotetramer containing two p18 and two p10 subunits ). Active caspase-8 then initiates the apoptotic program.
Cells can die in two ways through CD95 (Scaffidi et al, 1998; Barnhart et al, 2003) . Type I cells release large amounts of active caspase-8 from the DISC through efficient recruitment of FADD to the DD of CD95. This is sufficient to directly cleave and activate caspase-3. Type II cells, by contrast, produce very little active caspase-8 at the DISC. This, however, is sufficient to cleave the proapoptotic BH3 domain only containing Bcl-2 family member Bid Luo et al, 1998) , causing its translocation to the mitochondria where it induces the release of mitochondrial factors which ultimately enhance the apoptotic signal. A number of early events in CD95 signaling have been described. Upon stimulation, CD95 forms SDS-and b-mercaptoethanol stable aggregates (Kischkel et al, 1995; Kamitani et al, 1997; Papoff et al, 1999) . At this time, CD95 also forms higher order aggregates (Henkler et al, 2005) and signaling protein oligomerization structures (SPOTS) which are visible by immunofluorescence microscopy. CD95 has been shown to localize to membrane rafts (Hueber et al, 2002; Eramo et al, 2004; Muppidi and Siegel, 2004; Legembre et al, 2006) . Constitutive association with membrane rafts is mainly found in Type I cells (Eramo et al, 2004; Muppidi and Siegel, 2004) and these rafts colocalize with signaling protein oligomeric transduction structures (SPOTS) . In Type II cells, CD95 is absent from rafts but can be recruited into these detergent-resistant membrane (DRM) structures. As a next step of CD95 signaling, the receptor forms caps . The localization of CD95 to rafts and the formation of caps is enhanced by the action of ceramide (Cremesti et al, 2001; Grassme et al, 2003) . We have previously shown that the caps represent internalizing CD95 receptor . This internalization is more pronounced in Type I cells Eramo et al, 2004) . More recently, we demonstrated the internalization of CD95 occurs through an endosomal pathway which involves a classical clathrin-coated pit-mediated endocytosis (Lee et al, 2006) . Furthermore, we showed that most of the DISC forms after receptor-containing vesicles have reached an endosomal compartment, and that inhibition of internalization reduces formation of the DISC and inhibits apoptosis signaling (Lee et al, 2006) .
Two steps in the signaling initiation by CD95 have not been defined clearly. First, the earliest event during CD95 signaling, the formation of aggregates that are visible as SDS-resistant bands on SDS-PAGE, have been suggested to not be required for CD95 apoptosis signaling (Lee and Shacter, 2001 ; Legembre et al, 2003) . Second, while there is increasing consensus on the involvement of membrane rafts in CD95 signaling, it is unclear what mechanism causes CD95 to localize to rafts. Many membrane proteins that are found in membrane rafts carry post-translational modifications such as N-myristoylation and/or S-palmitoylation (Thomas et al, 2004) . Palmitoylated proteins localized in rafts include Gsa GTPases and src kinases (Smotrys and Linder, 2004) .
We now report that a single species of SDS-stable CD95 aggregates which forms in response to apoptosis-inducing stimulation is found in multimega Dalton CD95 structures we termed the hiDISC (high molecular weight DISC). It is in the hiDISC that FADD and caspase-8 are recruited to CD95 and that caspase-8 is activated. Most of the hiDISC is located outside of DRMs. Finally, we demonstrate that hiDISC formation is regulated by palmitoylation of CD95 at cysteine 199. Our data provide new insights into the very early apoptosis signaling of CD95 before activation of caspase-8.
Results
The DISC forms preferentially at SDS-stable CD95 aggregates We and others have previously shown that in order for CD95 to induce apoptosis, the receptor needs to form higher order aggregates (Kischkel et al, 1995; Kamitani et al, 1997; Papoff et al, 1999; Siegel et al, 2004; Henkler et al, 2005) . One of the apoptosis-inducing anti-CD95 antibodies is the anti-APO-1-3 (IgG3) antibody (Trauth et al, 1989) . When cells are stimulated with an IgG2b switch variant of this antibody (anti-APO-1-2) CD95 is crosslinked, however this antibody does not induce a level of CD95 aggregation sufficient to induce apoptosis (Lee et al, 2006) . It has been shown that CD95 aggregation can be seen as a SDS-and b-mercaptoethanolresistant species of CD95 on SDS-PAGE (for simplicity referred to as SDS-stable or CD95 hi ) which migrate in the range of 90-200 kDa depending on the cell type (Kischkel et al, 1995; Kamitani et al, 1997; Papoff et al, 1999) . We argued that if SDS-stable aggregates are the result of intense aggregation of CD95 and necessary for apoptosis induction, then the DISC should preferentially form at aggregated (SDS-stable) CD95. To test this, we stimulated SKW6.4 cells with leucine zippertagged CD95L (LzCD95L) for 10 min which resulted in a low level appearance of an SDS-stable form of CD95 in total cell lysates (CD95 hi in Figure 1A , lane 2). In order to test which form of CD95 is associated with the DISC components, we immunoprecipitated caspase-8 from untreated cells and cells treated with LzCD95L. All DISC components (c-FLIP L , FADD, caspase-10 and CD95) were associated with caspase-8 only in cells treated with CD95L, confirming that complex formation was strictly stimulation dependent. Interestingly, we detected predominantly CD95
hi with little 48 kDa CD95 associated with caspase-8 ( Figure 1A , lane 4). We also performed kinetics and tested two other cell lines (H9 and ACHN) with the same result ( Figure 1B and data not shown). The ratio of CD95 hi to CD95 associated with caspase-8 was much higher than the ratio seen in cell lysates. The same result was obtained when FADD was immunoprecipitated from lysates ( Figure 1C ). Whereas in cell lysates little CD95 hi could be detected, it was greatly enriched by immunoprecipitating the DISC component FADD. In summary, our data establish first that SDS-stable CD95 cannot only be detected in cells stimulated with antibodies but also with CD95L, and second that these CD95 aggregates are the sites at which the DISC forms and in fact represent 'activated' CD95.
Stimulation of CD95 causes formation of supramolecular signaling complexes (hiDISC) that contain FADD and caspase-8 SDS-stable forms of CD95, while often referred to as aggregated CD95, are not a true a measure of the level of receptor aggregation. They only reflect a conformational change in CD95 that interferes with SDS micelle formation when preparing proteins for SDS-PAGE. To determine whether SDS-stable CD95 really represents high molecular weight complexes of CD95, we performed analyses using sucrose gradients. We chose a continuous gradient of 10-50% (w/w) sucrose, which allows separation of proteins and native protein complexes according to their Stoke's radius with medium to very high molecular weights (Supplementary Figure S1 ). Post-nuclear supernatants of SKW6.4 cells were separated using these sucrose gradients ( Figure 2A ). In unstimulated cells, the three major DISC components CD95, FADD and caspase-8 sedimented in the fractions that best correlated with the molecular weight of the monomeric proteins. This changed dramatically when cells were stimulated with anti-APO-1-3. In addition to the monomeric proteins, higher molecular weight structures were detected both in terms of migration on SDS-PAGE as well as from their sedimentation in the gradients. Stimulation caused formation of three new SDS-stable forms of CD95, one at around 90 kDa (fractions 10-12, double lined box), one at more than 200 kDa (fractions 10-13) and one at 180 kDa (now termed CD95 hi ) sedimenting at very high molecular weights (fractions 1-9). Calibration with high molecular weight marker proteins and extrapolation suggests a size of these complexes between one and seven mega Dalton (Supplementary Figure S1) . Both FADD and caspase-8 cosedimented with these very large complexes of CD95 (high molecular weight DISC, hiDISC), suggesting that they are part of these complexes ( Figure 2B ). No full-length caspase-8 or its fully mature cleavage products were found in hiDISCs consistent with a model in which caspase-8 is activated when associated with CD95 in the hiDISC and active caspase-8 subunits are then released. The cells in Figure 2B were stimulated for 2 h representing a late stage in apoptosis. However, hiDISC could be detected as early as 10 min after stimulation (data not shown and Figure 3B ). CD95 has been shown to be itself proteolytically processed during apoptosis (Kamitani et al, 1997) . This proteolytic event, which generates a 95 kDa CD95 aggregate, occurs late after initiation of apoptosis and cannot be blocked by caspase inhibitors. It was proposed to be generated from the high molecular weight CD95 aggregates. Indeed, a 95 kDa CD95 SDS-stable band appeared at late but not at early time points (double lined box in Figure 2B and Figure 3B and C). This form of CD95 did not cosediment with any of the DISC components indicating that it is no longer part of the hiDISC. To test whether hiDISC formation correlates with apoptosis induction, we stimulated SKW6.4 cells with anti-APO-1-2 ( Figure 2C ). The anti-APO-1-2 antibody does not cause aggregation, capping, internalization of CD95, or DISC formation and hence does not induce apoptosis (Lee et al, 2006) . Interestingly, all SDS-stable forms of CD95, including CD95 hi , were detected. However, in these nondying cells, hiDISC could not be detected. These data suggest that while binding of anti-CD95 antibodies can induce formation of SDS-stable CD95, only agonistic antibodies (and the CD95L see Figure 4 ) cause formation of the hiDISC leading to apoptosis. One of the most significant findings of these experiments is that the fractions which contained CD95 hi were devoid of 48 kDa monomeric CD95. This strongly suggests that this form of SDS-stable CD95, which was also enriched in caspase-8 immunoprecipitates, represents an active form of CD95 required to induce apoptosis. The fact that other SDS-stable species of CD95 were not found in hiDISC fractions suggests that these species are formed in response to antibody binding alone and are not required for apoptosis induction through CD95. This finding provides an explanation for the controversial reports on the relevance of SDS-stable CD95 for CD95-induced apoptosis signaling. Only selected SDS-stable forms of CD95 are required for the receptor to signal apoptosis. We noticed that cells expressing endogenous CD95 tend to produce a higher number of different SDS-stable forms of CD95 than cells expressing exogenous CD95 (data not shown). When MCF7(FB) cells (Stegh et al, 2002) were treated with anti-APO-1-3, only the CD95 hi form of SDS-stable CD95 formed (Supplementary Figure S2B) , and this was almost exclusively found in fractions corresponding to the hiDISC. Similar to the results obtained with SKW6.4 cells, both FADD and caspase-8 were found in the high-density fractions. Also, mostly, p41/43 caspase-8 cleavage intermediates cosedimented with hiDISC, while almost all of the full-length caspase-8 was detected in fractions of low density. Similar to the SKW6.4 cells, anti-APO-1-2 could induce CD95 hi , however this stimulus was insufficient to cause formation of the hiDISC (Supplementary Figure S2C) . In a control experiment, we crosslinked the anti-APO-1-2 with protein A which enables the antibody to kill (Lee et al, 2006) . In this case, CD95 hi was able to form hiDISC (Supplementary Figure S2D) . Identical results were obtained from SKW6.4 cells which also die in response to crosslinked anti-APO-1-2 (data not shown and Lee et al, 2006) .
The caspase-8 containing hiDISC forms after release of the stimulating antibody As both agonistic as well as nonagonistic anti-APO-1 antibodies cause formation of SDS-stable CD95 hi sedimenting in fractions 10-12, we hypothesized that they form in response to anti-CD95 binding. To directly test the possibility that all CD95 hi isoforms detected in the sucrose gradients were simply a result of bound crosslinked antibodies, we treated cells with biotinylated anti-APO-1-3 for different times and detected cell-bound antibody by Western blotting using streptavidin-HRP. At 10 min after treatment, a small amount of CD95 hi began to move into fractions of higher molecular weight ( Figure 3B , fractions 4-12). Interestingly, a substantial amount of full-length caspase-8 and FADD (data not shown) was also recruited into these fractions, yet the biotinylated antibody could only be detected in fractions 10-12. This also did not change when cells were stimulated for up to 2 h ( Figure 3C ). At this time point, most of caspase-8 was found to be cleaved, and CD95 had reached maximal aggregation. However, even under these conditions, we still could not detect the stimulating antibody in any of the high-density fractions. These data suggest that while binding of anti-CD95 antibodies alone can induce formation of SDS-stable aggregates of CD95, the actual stimulus is no longer required for CD95 to form the hiDISC nor to recruit and activate caspase-8. This result is consistent with our recent report on the ability of membrane-bound CD95L to induce internalization of CD95 (Lee et al, 2006) in which we failed to detect internalized CD95L bound to the active receptor species. While the stimulating antibody does not seem to stay bound to internalized CD95, our data on the isolation of CD95-containing receptosomes (see Figure 7B ) suggest that the biotinylated antibody is found in the magnetically isolated endosomes, dissociated from CD95 but still allowing for the isolation of magnetized vesicles.
Caspase-8 exclusively associates with a single species of SDS-stable CD95 in the hiDISC
Although caspase-8 and FADD were observed to cosediment with SDS-stable CD95 in high-density fractions, this is not sufficient evidence for a direct interaction. To test whether caspase-8 was bound to CD95 as part of the hiDISC, we depleted caspase-8 from cell lysates of SKW6.4 cells stimulated with LzCD95L by three consecutive immunoprecipitations with the anti-caspase-8 antibody C15 before loading the lysate onto the sucrose gradient ( Figure 4B ). In the control treated lysates, a strong CD95 hi band was detected in fractions 1-13 ( Figure 4A ). Lysates depleted of caspase-8 showed complete removal of caspase-8 ( Figure 4B ). The amount of CD95 and FADD in fractions 10-18 representing lower molecular weight complexes and monomeric proteins was unchanged, indicating that none of these proteins were associated with caspase-8 in response to CD95L stimulation. An unrelated protein transferrin receptor was also not affected by the removal of caspase-8. In contrast, a clear reduction of FADD in fractions 3-9 was apparent, suggesting that FADD in these fractions was complexed with caspase-8. We also detected a significant decrease of CD95 hi in fractions 3-13, suggesting that CD95 in these fractions is associated with caspase-8 establishing the existence of hiDISC complexes comprising CD95, FADD and caspase-8. We could not establish an association of DISC components in the very high molecular weight complexes found in fractions 1 and 2. This could be the result of insolubility of these high molecular weight complexes.
The hiDISC forms inside and outside of detergent resistant membranes (DRMs)
Although most of CD95 hi was detected in fractions representing very high molecular weight ranges, we noticed that in all sucrose gradients a small fraction of the 180 kDa CD95 hi sedimented at around 18 kDa (see stippled boxes in Figures 2B, 3B and C and 4A; Supplementary Figures S2B and S2D ). This form of active CD95 complex, therefore, had a much lower buoyancy than expected from its composition, which pointed at association with lipids that are found in DRMs (Thomas et al, 2004) . CD95 has been reported by a number of groups to either reside in or to be recruited into membrane rafts (Hueber et al, 2002; Eramo et al, 2004; Muppidi and Siegel, 2004; Legembre et al, 2006) . It was also shown that caspase-8 is activated in membrane rafts , and that CD95 internalizes from these specialized membrane structures (Eramo et al, 2004) . DRMs are isolated through their resistance to detergent solubilization followed by a discontinuous density gradient of sucrose or OptiPrep . This results in an enrichment of proteins complexed with lipids attributing to the high buoyancy (Thomas et al, 2004) . In contrast, the continuous sucrose gradient used in our study allows us to determine the molecular weight of native protein complexes. A comparison of the two different methods is illustrated in Supplementary Figure S3 . In order to determine whether CD95 hi forms in DRMs, we reproduced the DRM/membrane raft isolation protocol published by Muppidi and Siegel (2004) . As published, we found a certain part of CD95 and to some extend of FADD and caspase-8 localized in the DRM fractions 4 and 5 even in unstimulated cells. DRMs were identified by the presence of the raft marker Lyn ( Figure 5A ). In cells stimulated with anti-APO-1-3, the amount of CD95 in DRMs did not change, however the amount of FADD and processed caspase-8 increased ( Figure 5B) . A significant amount of CD95 hi was found in the DRM fractions giving an explanation for the FADD and caspase-8 recruitment, which could not be explained before . All of a lower migrating SDS-stable form of CD95 (95 kDa) was found in the soluble fractions which also contains a significant amount of CD95 hi . It could be argued that the postnuclear supernatants prepared for the sucrose gradients excluded detergent-insoluble CD95, as it might have been removed by spinning down nuclei. In order to test this, we analyzed the postnuclear supernatant and the nuclei containing pellet by SDS-PAGE and anti-CD95 Western blotting (Supplementary Figure S4) . This experiment confirmed that in cells stimulated through CD95 for 20 min, a substantial amount of CD95 had formed SDS-stable aggregates. It also demonstrated that almost none of the specific SDS-stable species of CD95 that is found in the hiDISC (CD95 hi ) was found in the pellet, confirming that all of CD95 was loaded onto the sucrose gradients and that the results of the two gradients can directly be compared. Taken together, our data would be consistent with a model in which part of CD95 internalizes from within DRMs after stimulation followed by formation of the hiDISC to recruit and activate caspase-8.
Formation of CD95
hi is greatly enhanced by palmitoylation of CD95 CD95's presence in rafts has been shown to be important for apoptosis signaling. Many of the raft-localized proteins carry lipid modifications that direct them into rafts. A modification frequently found in raft-localized proteins is palmitoylation (Smotrys and Linder, 2004) . Such modified proteins include among many others the src kinase Lyn that we used as a marker protein for rafts. While there is no clearly defined consensus motif for this modification (Shenoy-Scaria et al, 1993; Jones, 2004) , palmitoylation of transmembrane proteins very often occurs at a cysteine residue located within 10 amino acids of the transmembrane domain in the juxtamembrane domain rich in basic amino acids. We analyzed the juxtamembrane region of CD95 and found one of the two intracellular cysteine residues (C199) in the intracellular domain of CD95 to be part of a putative palmitoylation motif that is also present in murine CD95 ( Figure 6A ). In order to assess whether palmitoylation of CD95 could regulate formation of CD95 signaling complexes, we treated cells with the palmitoylation inhibitor 2-bromopalmitic acid (2-BrPA). This treatment prevented formation of CD95 hi . Similarly, we treated lysates with KOH to cleave the thioester bond between CD95 and the fatty acid and again observed a block in CD95 hi formation ( Figure 6B ). To directly test whether endogenous CD95 is palmitoylated, we metabolically labeled SKW6.4 cells with [ 3 H]palmitate, immunoprecipitated CD95, and after SDS-PAGE subjected the gel to autoradiography ( Figure 6C ). We clearly could detect palmitoylated CD95. The modification of endogenous CD95 could hi is sensitive to the palmitoylation inhibitor 2-bromo-palmitic acid (2-BrPA) and alkaline treatment. (C) Endogenous CD95 is palmitoylated. SKW6.4 cells were metabolically labeled with 0.5 mCi/ml [9,10(n) 3 H]palmitic acid for 3 h and CD95 was immunoprecipitated with the C20 antibody. (D) CD95 is palmitoylated on cysteine 199. Flag-tagged CD95 wt and C199S mutant were expressed in 239T, metabolically labeled with 0.25 mCi/ml [9,10(n) also been blocked by treating the cells with 2-BrPA (data not shown). Consistent with what is known about protein palmitoylation (Jones, 2004) , we did not see a change in palmitoylated CD95 in cells stimulated to undergo CD95-mediated apoptosis, suggesting that the modification is not regulated during CD95 signaling. To confirm cysteine 199 as the palmitoylation site, we mutated it to serine. This mutant could not be labeled by palmitate, confirming that it is cysteine 199 in CD95 that is palmitoylated ( Figure 6D ).
Palmitoylation of CD95 enhances its aggregation, internalization and activity to mediate apoptosis
To test the significance of the palmitoylation for CD95 aggregation, we compared the activity of the C199S (CS) mutant and another C199 mutant in which we replaced cysteine with alanine (CA) with that of wt CD95 to form CD95 hi . We noticed that transient expression of CD95 in 293T cells led to constitutive aggregation of CD95 involving formation of CD95 hi sedimenting at very high density in sucrose gradients (Supplementary Figure S5) . Both palmitoylation mutants showed severely reduced CD95 hi ( Figure 7A ). In contrast, the internalization-deficient mutant Y291F (YF) (Lee et al, 2006) did not exhibit a reduction of the amount of CD95 hi . The latter data suggest that while most of CD95 hi is formed during or after internalization, internalization is not required for CD95 hi formation. Our data provide evidence for a model in which CD95 internalizes from supramolecular platforms that are detectable as SDS-stable CD95. When palmitoylation is prevented, less CD95 can be recruited to these platforms and hence less CD95 is available to internalize and to form hiDISC complexes. As a fraction of CD95 was found in DRMs in a raft gradient, we wondered whether cysteine 199 is important for aggregation of CD95 and hiDISC formation or for localization to DRMs. We therefore directly compared the tendency of wild-type CD95 and the C199S and Y291F mutants to sediment in hiDISC fractions in a sucrose gradient and to appear in DRMs in the raft gradient (Supplementary Figure S5) . Owing to the constitutive aggregation of CD95 in 293T cells, part of wild-type CD95 was detected in the fractions that correspond to the hiDISC fractions (Supplementary Figure S5A) . About the same amount of the YF mutant also localized to these fractions. In contrast, the association of the CS mutant with these fractions was decreased indicating that palmitoylation of CD95 promotes formation of supramolecular receptor aggregates. In contrast, in the analysis involving the raft gradient, similar amounts of all constructs located to fractions 4 and 5 containing membrane raft proteins. These data suggest that at least in 293T cells an intact palmitoylation site in CD95 is more important for receptor aggregation than for localization to DRMs.
Inhibition of palmitoylation of CD95 would be expected to reduce the amount of CD95 that can internalize and signal apoptosis. To directly test this, we applied a technique we recently used to demonstrate that the DISC forms after internalization of the CD95 receptor-the isolation of magnetic receptosomes (Lee et al, 2006) . In this analysis, we found that most of CD95 hi formed after the receptor had reached an endosomal compartment ( Figure 7B , lanes 4 and 5), suggesting that while formation of CD95 hi was likely initiated at the plasma membrane it proceeded after receptor internalization. Consistent with our previous report processing of caspase-8 peaked at 10-30 min at a time when the isolated vesicles contained Rab4 and cathepsin D indicating their endosomal/lysosomal nature ( Figure 7B , lanes 4 and 5). Two cytoplasmic control proteins, calpain-2 and IkB kinase a, were not enriched with the isolated receptosomes. Interestingly, the raft marker protein Lyn in part colocalized with the internalizing CD95 suggesting that membrane rafts do not remain at the cell surface. In cells treated with 2-BrPA, both internalization of CD95 and formation of CD95 hi were severely reduced ( Figure 7B, lanes 7-12) . Correspondingly, processing of caspase-8 and formation of the p18 active subunit was delayed. These data were confirmed by confocal microscopy ( Figure 7C ). Triggering CD95 induced its internalization, which was visible as CD95-positive endosomal vesicles 1 h after stimulation. When cells that had been treated with 2-BrPA were analyzed in the same way, CD95 remained mostly at the cell surface ( Figure 7C ). To quantify the effect of 2-BrPA, we performed a CD95 internalization assay as described previously . We detected a significant reduction of receptor internalization in SKW6.4 cells treated with 2-BrPA and anti-APO-1 30 min after raising the temperature to 371C ( Figure 7D ). Even before the temperature was raised, about 10% of CD95 began to internalize and this very early internalization was also reduced by inhibiting palmitoylation. We next tested whether the reduction in internalization caused by inhibition of palmitoylation translated into reduced processing of caspase-8 ( Figure 7E ). Cells treated with 2-BrPA showed a reduction of the formation of the active caspase-8 subunit p18, suggesting that palmitoylation is important for apoptosis induction. We detected reduced amounts of full-length caspase-8 in the 2-BrPA-treated cells even without apoptosis induction indicating an unknown mechanism of degradation. However, this pool of caspase-8 was unlikely involved in hiDISC formation, as we did not detect a reduction of fulllength caspase-8 associated with CD95-containing receptosomes for up to 60 min of stimulation (compare Figure 7B , lanes 6 and 12). Finally, we transiently expressed wild-type and C199S mutant CD95 in NIH3T3 cells, stimulated the human receptor with anti-APO-1-3, and monitored activation of caspase-3 in cell lysates using a fluorogenic substrate cleavage assay ( Figure 7F ). Induction of apoptosis through the mutant receptor was reduced compared to wild-type CD95 indicating that palmitoylation of CD95 at C199 enhances apoptosis signaling. Our data establish that CD95 is palmitoylated at cysteine 199, and that this post-translational modification facilitates the formation of CD95 supramolecular structures of very high molecular weight (hiDISC complexes) and the internalization of the receptor. Although internalization of CD95 is not essential for hiDISCs formation, it is at these structures that FADD and caspase-8 are recruited and caspase-8 is activated. Our data consolidate different phenomena of early CD95 apoptosis signaling into one signaling model and identify palmitoylation as a novel posttranslational modification that enhances apoptosis signaling through CD95.
Discussion
When apoptosis signaling through CD95 was first described, it was assumed that the receptor is located at the cell surface and that binding of its ligand would result in a conformational change which would induce oligomerization of the receptor, bringing together the intracellular DD and thereby increasing the affinity of CD95 to bind FADD. This step would trigger recruitment of caspase-8 molecules which would activate each other through induced proximity (Boatright et al, 2003; Peter and Krammer, 2003) . It was also recognized that cells can die through the Type I or the Type II pathways . In subsequent years, it was shown that CD95 is preassociated at the plasma membrane (Siegel et al, 2000) , and in Type I cells is localized to membrane rafts, often referred to as lipid rafts (Eramo et al, 2004; Muppidi and Siegel, 2004) . While there is some controversy over a difference in localization of CD95 to rafts in Type I and Type II cells (Hueber et al, 2002; Eramo et al, 2004; Muppidi and Siegel, 2004) , there is good evidence that a certain fraction of CD95 is located in detergent-insoluble structures.
These data are complemented by other reports demonstrating that after stimulation, CD95 forms caps from which the receptor internalizes through a endosomal pathway in an actin-dependent fashion Algeciras-Schimnich and Peter, 2003; Lee et al, 2006) . More recently, we demonstrated that most of the recruitment of the DISC does not occur at the plasma membrane, but after the internalizing receptor has reached an endosomal compartment (Lee et al, 2006) . In fact, blocking internalization of CD95 in Type I cells caused a profound loss of the apoptosisinducing activity (Lee et al, 2006) .
Available data point at two major regulatory events during early CD95 signaling before activation of caspases: (1) the localization to membrane rafts and (2) the formation of high molecular weight aggregates that then form the basis for internalization of the receptor and subsequent recruitment of the DISC components. In this work, we have studied these two steps of CD95 signaling. Highly aggregated CD95 forms SDS-stable bands of different sizes on SDS-PAGE. Only one form of around 180 kDa (CD95 hi ) was found to shift to very high molecular weight structures of many mega Dalton in size, which we have termed hiDISC. The hiDISC is likely different from small amounts of low molecular weight DISC that forms at the cell surface before the initiation of receptor internalization in Type I cells or at the surface of Type II cells that do not internalize CD95. Moreover, this low molecular weight DISC is capable of triggering nonapoptotic signaling (Barnhart et al, 2004; Lee et al, 2006) . We now demonstrate that in Type I cells FADD and caspase-8 are recruited to the hiDISC and caspase-8 activation is initiated. Although there was some evidence for the significance of SDS-stable CD95 (Kischkel et al, 1995; Kamitani et al, 1997; Papoff et al, 1999; Algeciras-Schimnich et al, 2002; Henkler et al, 2005) , two studies suggested that SDS-stable CD95 aggregates are not required for CD95 apoptosis signaling (Lee and Shacter, 2001; Legembre et al, 2003) . In the first study, it was shown that treating cells with the serine protease inhibitor TLCK resulted in a reduction of SDS-stable CD95 aggregates without affecting the sensitivity of cells to CD95-mediated apoptosis (Lee and Shacter, 2001 ). However, the amount of detected CD95 aggregates in this study could only be reduced, and aggregation was not completely prevented. In the second study, it was demonstrated that the CD95 aggregates are only found in cells treated with agonistic anti-CD95 antibodies but not with CD95L (Legembre et al, 2003) . Our data now demonstrate that these aggregates do form in cells treated with CD95L. However, the data show that only one of the detected SDSstable forms is being recruited to the hiDISC providing some explanation for the discrepancy between studies. We clearly demonstrate that depleting caspase-8 from CD95-stimulated lysates selectively removes CD95 hi present in the hiDISC from these lysates (see Figure 4B ).
SDS-stable CD95 hi is likely the result of the formation of supramolecular oligomers (Henkler et al, 2005) which form independent of the activation of caspases (AlgecirasSchimnich et al, 2002; Henkler et al, 2005) . It appears that these aggregates are similar to SPOTS that form without the need for the intracellular domain of CD95 . It was suggested that SPOTS form after SDS-stable CD95 complexes have formed. We now demonstrate that formation of SDS-stable CD95 alone does not allow cells to undergo apoptosis. CD95 hi needs to move into the hiDISC. While the nonagonistic anti-APO-1 IgG2b antibody induces SPOTS (Lee et al, 2006) and CD95 hi , it does not induce hiDISC complexes. This suggests that first SPOTS appear together with CD95 hi , and then high-order aggregates visible as hiDISC complexes form while the receptor begins to internalize.
We detected a small amount of CD95 hi in very light fractions of the sucrose gradients consistent with some localization of this CD95 species to DRMs, which contain both aggregates of lipid rafts and proteins. However, most of CD95 was found in fractions of extremely high density inconsistent with DRM localization. Correspondingly, although we did detect a significant amount of CD95 in the DRM fractions, we detected a more substantial amount of CD95 hi in more dense soluble fractions. Our analysis, which for the first time compared membrane raft gradients and classical sucrose density gradients do not contradict the membrane raft concept for CD95 signaling. However, while recruitment and activation of caspase-8 may occur in membrane rafts, we conclude that CD95 signals apoptosis from high molecular aggregates inside and outside of DRMs. This differentiated view allows us to explain some of the inconsistencies in the literature. In one study, it was observed that while the raft marker Thy 1 was released from membrane rafts of HUT78 cells upon treatment with the cholesteroldepleting reagent methyl-b-cyclodextrin (MBCD), CD95 localization to membrane rafts did not change. It was concluded that CD95 might be located to the MBCD-resistant sphingolipid-rich core of membrane rafts. Likewise, we have previously shown that CD95 apoptosis sensitivity of Type I cells could not be affected by MBCD treatment (AlgecirasSchimnich et al, 2002) .
Our integrated model of early CD95 signaling is also consistent with another recent study in which it was shown that the enzyme sphingomyelinase (SM) synthase 1 (SMS1) can increase CD95-induced apoptosis by increasing the amount of SM in membrane rafts, allowing a more efficient translocation of CD95 into membrane rafts (Miyaji et al, 2005) . This study found that the amount of SDS-stable CD95 aggregates was reduced in cells lacking SMS1, suggesting a contribution of membrane rafts to formation of CD95 hi . The second major finding of our study is that CD95 is palmitoylated at cysteine 199. Membrane rafts have been estimated to comprise up to 40% of the membrane of immune cells (Thomas et al, 2004) . Proteins that are N-myristoylated and/or S-palmitoylated partition into membrane rafts, whereas those modified by unsaturated fatty acids or prenyl groups are excluded. Based on our results we now postulate that palmitoylation of CD95 augments CD95 signaling in two ways which are not mutually exclusive. It results in a more efficient recruitment of CD95 into DRMs, and it allows for a more efficient aggregation of CD95, which becomes visible as an increase in the amount of SDSstable CD95. We currently favor the latter mechanism which has been shown for VIP-21 caveolin (Monier et al, 1996) . A detailed analysis revealed that a mutant caveolin that cannot be S-acylated lost the ability to form aggregates that were tight enough to resist SDS-PAGE. This study demonstrated that palmitoylation can increase the stability of oligomers. Similarly, CD95 with a mutated palmitoylation site when overexpressed in 293T cells was found in DRMs as efficiently as wild-type CD95. However, it was less active in participating in high molecular weight aggregates of CD95 as detected by sucrose gradients. In summary, this study has identified two major aspects of CD95 signaling. First, a specific 180 kDa species (CD95 hi ) of SDS-stable CD95 aggregates which forms upon stimulation is found in multimega Dalton complexes that are the site of FADD and caspase-8 recruitment and activation. Second, this process is augmented by palmitoylation of CD95 which facilitates efficient formation of CD95 hi inside and outside of membrane rafts.
Materials and methods

Cell lines
The B-lymphoblastoid cell line SKW6.4 and the T-cell line H9 were cultured in RPMI supplemented with 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin and maintained in 5% CO 2 at 371C. MCF7-Fas-Bcl-x L (MCF7-FB) were cultured in the same media supplemented with 200 mg/ml G418 (Cellgro, Herndon, VA) and 150 mg/ml Hygromycin B (Sigma). The human embryonic kidney cell line 293T and the mouse fibroblast cell line NIH3T3 were cultured in DMEM containing 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin and maintained in 5% CO 2 at 371C.
Antibodies, plasmids, reagents and mutagenesis
Monoclonal antibodies against FADD, EEA1, Lyn and FITC-antihuman CD95 (DX2) were purchased from Pharmingen (San Diego, CA). The monoclonal antibodies against Flag (M2) and b-actin (AC-15) were purchased from Sigma (St Louis, MO). The anti-Rab4 antibody was obtained from Stressgen. The cathepsin D and calpain-2-specific antibodies were from Calbiochem. The polyclonal rabbit anti-caspase-10 was from Cell Signaling. The rabbit polyclonal anti-CD95 (C20), the anti-FADD (H-181) and the IKKa (H-744) antiserum, and the HRP-conjugated anti-rabbit were from
